{"DataElement":{"publicId":"4353914","version":"1","preferredName":"Reverse Transcriptase-Polymerase Chain Reaction Biomarker GeneType","preferredDefinition":"The response regarding the generic type of gene being measured using RT-PCR.","longName":"RT-PCR_BMRK_GN_TYP","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"4353913","version":"1","preferredName":"Reverse Transcriptase-Polymerase Chain Reaction Biomarker Gene","preferredDefinition":"A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase._A variation in cellular or biochemical components or processes, structures, or functions that is objectively measurable in a biological system and that characterizes normal biologic processes, pathogenic processes, an organism's state of health or disease, likelihood of developing a disease, prognosis, or response to a particular therapeutic intervention. Biomarkers include but not limited to such phenotypic parameters as specific enzyme or hormone concentration, specific gene phenotype, presence or absence of biological substances._A functional unit of heredity which occupies a specific position on a particular chromosome and serves as the template for a product that contributes to a phenotype or a biological function.","longName":"2176999v1.0:4353911v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2176999","version":"1","preferredName":"RT-PCR","preferredDefinition":"RT-PCR is short for reverse transcriptase-polymerase chain reaction. It is a technique in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase. (from Wikipedia)","longName":"RT-PCR","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Reverse Transcriptase-Polymerase Chain Reaction","conceptCode":"C18136","definition":"A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7ACC-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4353911","version":"1","preferredName":"Biomarker Gene","preferredDefinition":"A variation in cellular or biochemical components or processes, structures, or functions that is objectively measurable in a biological system and that characterizes normal biologic processes, pathogenic processes, an organism's state of health or disease, likelihood of developing a disease, prognosis, or response to a particular therapeutic intervention. Biomarkers include but not limited to such phenotypic parameters as specific enzyme or hormone concentration, specific gene phenotype, presence or absence of biological substances.:A functional unit of heredity which occupies a specific position on a particular chromosome and serves as the template for a product that contributes to a phenotype or a biological function.","longName":"C16342:C16612","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gene","conceptCode":"C16612","definition":"A functional unit of heredity which occupies a specific position on a particular chromosome and serves as the template for a product that contributes to a phenotype or a biological function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB300F3A-1242-153A-E040-BB89AD436C7D","latestVersionIndicator":"Yes","beginDate":"2014-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-06-06","modifiedBy":"ONEDATA","dateModified":"2014-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB300F3A-1253-153A-E040-BB89AD436C7D","latestVersionIndicator":"Yes","beginDate":"2014-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-06-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"NWU2013-01-03_ghd_06-06-2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4353892","version":"1","preferredName":"RT-PCR Biomarker Gene Type","preferredDefinition":"the type of molecular marker utilizing DNA-PCR (polymerase chain reaction)._A functional unit of heredity which occupies a specific position on a particular chromosome and serves as the template for a product that contributes to a phenotype or a biological function._Quantitative PCR: a method to measure very small amounts of RNA transcripts as cDNA targets. There are two strategies currently used, one is called Competitive RTPCR and the other is called Real-Time PCR._A variation in cellular or biochemical components or processes, structures, or functions that is objectively measurable in a biological system and that characterizes normal biologic processes, pathogenic processes, an organism's state of health or disease, likelihood of developing a disease, prognosis, or response to a particular therapeutic intervention. Biomarkers include but not limited to such phenotypic parameters as specific enzyme or hormone concentration, specific gene phenotype, presence or absence of biological substances._A functional unit of heredity which occupies a specific position on a particular chromosome and serves as the template for a product that contributes to a phenotype or a biological function.","longName":"RT_PCR_GN_TP","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Gene X","valueDescription":"Gene X","ValueMeaning":{"publicId":"4353893","version":"1","preferredName":"Gene X","longName":"4353893","preferredDefinition":"Gene X","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB300F3A-1185-153A-E040-BB89AD436C7D","latestVersionIndicator":"Yes","beginDate":"2014-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-06-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB300F3A-119E-153A-E040-BB89AD436C7D","beginDate":"2014-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-06-06","modifiedBy":"ONEDATA","dateModified":"2014-06-06","deletedIndicator":"No"},{"value":"Gene C","valueDescription":"Gene C","ValueMeaning":{"publicId":"4353894","version":"1","preferredName":"Gene C","longName":"4353894","preferredDefinition":"Gene C","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB300F3A-11A8-153A-E040-BB89AD436C7D","latestVersionIndicator":"Yes","beginDate":"2014-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-06-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB300F3A-11C1-153A-E040-BB89AD436C7D","beginDate":"2014-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-06-06","modifiedBy":"ONEDATA","dateModified":"2014-06-06","deletedIndicator":"No"},{"value":"Gene B","valueDescription":"Gene B","ValueMeaning":{"publicId":"4353895","version":"1","preferredName":"Gene B","longName":"4353895","preferredDefinition":"Gene B","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB300F3A-11CB-153A-E040-BB89AD436C7D","latestVersionIndicator":"Yes","beginDate":"2014-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-06-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB300F3A-11E4-153A-E040-BB89AD436C7D","beginDate":"2014-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-06-06","modifiedBy":"ONEDATA","dateModified":"2014-06-06","deletedIndicator":"No"},{"value":"Gene A","valueDescription":"Gene A","ValueMeaning":{"publicId":"4353896","version":"1","preferredName":"Gene A","longName":"4353896","preferredDefinition":"Gene A","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB300F3A-11EE-153A-E040-BB89AD436C7D","latestVersionIndicator":"Yes","beginDate":"2014-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-06-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB300F3A-1207-153A-E040-BB89AD436C7D","beginDate":"2014-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-06-06","modifiedBy":"ONEDATA","dateModified":"2014-06-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4353899","version":"1","preferredName":"Quantitative Reverse Transcriptase PCR Biomarker Gene Type","preferredDefinition":"Quantitative PCR: a method to measure very small amounts of RNA transcripts as cDNA targets. There are two strategies currently used, one is called Competitive RTPCR and the other is called Real-Time PCR.:A variation in cellular or biochemical components or processes, structures, or functions that is objectively measurable in a biological system and that characterizes normal biologic processes, pathogenic processes, an organism's state of health or disease, likelihood of developing a disease, prognosis, or response to a particular therapeutic intervention. Biomarkers include but not limited to such phenotypic parameters as specific enzyme or hormone concentration, specific gene phenotype, presence or absence of biological substances.:A functional unit of heredity which occupies a specific position on a particular chromosome and serves as the template for a product that contributes to a phenotype or a biological function.:Something distinguishable as an identifiable class based on common qualities.","longName":"C28408:C16342:C16612:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quantitative Reverse Transcriptase PCR","conceptCode":"C28408","definition":"Quantitative PCR: a method to measure very small amounts of RNA transcripts as cDNA targets. There are two strategies currently used, one is called Competitive RTPCR and the other is called Real-Time PCR.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Gene","conceptCode":"C16612","definition":"A functional unit of heredity which occupies a specific position on a particular chromosome and serves as the template for a product that contributes to a phenotype or a biological function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB300F3A-1216-153A-E040-BB89AD436C7D","latestVersionIndicator":"Yes","beginDate":"2014-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-06-06","modifiedBy":"ONEDATA","dateModified":"2014-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB300F3A-1171-153A-E040-BB89AD436C7D","latestVersionIndicator":"Yes","beginDate":"2014-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-06-06","modifiedBy":"HARTLEYG","dateModified":"2014-12-26","changeDescription":"NWU2013-01-03_ghd_06-06-14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Test","type":"Preferred Question Text","description":"Test","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB30CB6C-1734-2EC7-E040-BB89AD43452F","latestVersionIndicator":"Yes","beginDate":"2014-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-06-06","modifiedBy":"HARTLEYG","dateModified":"2014-12-26","changeDescription":"NWU2013-01-03_ghd_06-06-2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}